XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Crypto CLARITY Act Senate Vote: What Happens Next
A vote to advance legislation is a procedural threshold, typically a cloture motion or motion to proceed, that determines whether a bill can move to full Senate...
Altcoin Gains 53% as Bitcoin Holds Near $83,000
Starknet’s STRK token surged more than 53% intraday to nearly $0. 11, making it the standout mid-cap gainer of the weekend while Bitcoin continued trading sidew...
XRP Ledger Flaw Could Mint 18 Trillion XRP, RippleX Confirms
An AI agent built by Veria Labs identified a chained vulnerability in the XRP Ledger that could have created roughly 18 trillion XRP in a single transaction, ap...
Metaplanet Sold 10,000 BTC, Bought 11,000 at 9.3% Higher Price
The transaction sequence is straightforward on paper. Metaplanet offloaded 10,000 BTC , then turned around and acquired 11,000 BTC, resulting in a net increase...
Bitcoin Price Under Pressure After Houthi Attack
The reported Houthi strike on Saudi Arabia introduced a risk-off signal that weighed on Bitcoin, according to reporting from CryptoPotato . Geopolitical shocks...
Bitcoin, Ether and XRP Slide as Whale Accumulation Signals Emerge
Bitcoin, Ether, and XRP are sliding in tandem while on-chain observers report emerging whale accumulation signals, a pattern that has historically preceded shor...
